Determine the necessary mass, volume, or concentration for preparing a solution.
≥95% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Store at -20°C,Argon charged Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 27 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Product Introduction
Maximum absorption wavelength/emission wavelength: 748/780 nm
Recommended filter setting: 710 ex/760 em

Figure 1. T-cells isolated from the spleen were fluorescently stained with DiR and i.v. injected (5x106 cells/mouse) into a Nu/Nu mouse. Images above taken 24hrs post injection with IVIS Spectrum show cells homing to the spleen.
DiR dye is a lipophilic near-infrared cyanine fluorescent dye that can be used to dye cell membranes and other fat-soluble biological structures. A long chain of 18 carbons is inserted into the cell membrane to stain cells, while the transfer of dye between cells is negligible. DiR emits near-infrared fluorescence that can penetrate cells and tissues and is used for tracking in in vivo imaging.
DIR generally performs fluorescent staining of primary cells and can observe the distribution of in vivo imaging, (For example, the following cell embryonic stem cells, bone marrow derived stem cells, adipose derived stem cells, lymphocytes and erythrocytes),


Figure 2. DiR stock was prepared by dissolving 25 mg in 3 mL ethanol. Working solution of 320 µg/mL was prepared by diluting 199 µL of stock solution in 5 mL PBS. T-cells isolated from the spleen were incubated with 320 µg/mL DiR. After 30 min incubation, cells were spun down for 3 min at 1000 rpm at 4 ºC resulting in a blue pellet. Cells were washed twice in PBS and injected intravenously (5 x 106 cells/mouse). Control group was injected with 5 x 106 cells/mouse in PBS. Mice were imaged with IVIS Spectrum at 10 min, 1hr, 6hr and 24 hrs post injection. Ideal filter set for DiR imaging is 710 nm excitation and 760 nm emission. Mice were imaged dorsally as well as ventrally at all time points. Brain, bones, spleen, liver, lungs and kidneys were harvested for ex vivo imaging 24 hrs post injection.
Non-invasive in vivo imaging showed the homing process of injected T cells to the liver and spleen in real time, which was confirmed by ex vivo imaging.
References
Kalchenko et al., Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. Journal of Biomedical optics, September/October 2006, Vol 11(5).
| Pubchem Sid | 488202343 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488202343 |
| Canonical Smiles | CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2C(C1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCCCCCCCCCCCCCCCCC)(C)C.[I-] |
| IUPAC Name | 2-[7-(3,3-dimethyl-1-octadecylindol-1-ium-2-yl)hepta-2,4,6-trienylidene]-3,3-dimethyl-1-octadecylindole;iodide |
| InChIKey | JLIOTPLALDYAEH-UHFFFAOYSA-M |
| INCHI | 1S/C63H101N2.HI/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38-46-54-64-58-50-44-42-48-56(58)62(3,4)60(64)52-40-36-35-37-41-53-61-63(5,6)57-49-43-45-51-59(57)65(61)55-47-39-34-32-30-28-26-24-22-20-18-16-14-12-10-8-2;/h35-37,40-45,48-53H,7-34,38-39,46-47,54-55H2,1-6H3;1H/q+1;/p-1 |
| Isomeric SMILES | CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2C(C1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCCCCCCCCCCCCCCCCC)(C)C.[I-] |
| PubChem CID | 74405886 |
| Molecular Weight | 1013.41 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jan 10, 2026 | D131031 | |
| Certificate of Analysis | Jan 10, 2026 | D131031 | |
| Certificate of Analysis | Jan 10, 2026 | D131031 | |
| Certificate of Analysis | Jan 10, 2026 | D131031 | |
| Certificate of Analysis | Dec 12, 2025 | D131031 | |
| Certificate of Analysis | Dec 12, 2025 | D131031 | |
| Certificate of Analysis | Aug 12, 2025 | D131031 | |
| Certificate of Analysis | May 24, 2025 | D131031 | |
| Certificate of Analysis | May 24, 2025 | D131031 | |
| Certificate of Analysis | May 24, 2025 | D131031 | |
| Certificate of Analysis | May 24, 2025 | D131031 | |
| Certificate of Analysis | Feb 11, 2025 | D131031 | |
| Certificate of Analysis | Feb 11, 2025 | D131031 | |
| Certificate of Analysis | Feb 11, 2025 | D131031 | |
| Certificate of Analysis | Feb 11, 2025 | D131031 | |
| Certificate of Analysis | Dec 16, 2024 | D131031 | |
| Certificate of Analysis | Dec 16, 2024 | D131031 | |
| Certificate of Analysis | Dec 16, 2024 | D131031 | |
| Certificate of Analysis | Dec 16, 2024 | D131031 | |
| Certificate of Analysis | Oct 10, 2024 | D131031 | |
| Certificate of Analysis | Oct 10, 2024 | D131031 | |
| Certificate of Analysis | Oct 10, 2024 | D131031 | |
| Certificate of Analysis | Jun 20, 2024 | D131031 | |
| Certificate of Analysis | Jun 20, 2024 | D131031 | |
| Certificate of Analysis | Jun 20, 2024 | D131031 | |
| Certificate of Analysis | Jan 29, 2024 | D131031 | |
| Certificate of Analysis | Jan 29, 2024 | D131031 | |
| Certificate of Analysis | Jan 29, 2024 | D131031 | |
| Certificate of Analysis | Oct 23, 2023 | D131031 | |
| Certificate of Analysis | Oct 23, 2023 | D131031 | |
| Certificate of Analysis | Oct 23, 2023 | D131031 | |
| Certificate of Analysis | Oct 23, 2023 | D131031 | |
| Certificate of Analysis | Feb 04, 2023 | D131031 | |
| Certificate of Analysis | Feb 04, 2023 | D131031 | |
| Certificate of Analysis | Jun 30, 2022 | D131031 | |
| Certificate of Analysis | Jun 30, 2022 | D131031 | |
| Certificate of Analysis | Jun 30, 2022 | D131031 |
| Solubility | Solubility:Methanol (Slightly, Heated), Water (Very Slightly, Heated, Sonicated) |
|---|---|
| Sensitivity | Light sensitive |
| 1. Yajing Wang, Ziwei Ding, Shiqun Lv, Jie Liu, Jie Pan, Yingcong Yu, Jun Gao, Xianfeng Huang. (2023) Development of tLyP-1 functionalized nanoliposomes with tunable internal water phase for glioma targeting. JOURNAL OF LIPOSOME RESEARCH, [PMID:36974836] [10.1080/08982104.2023.2191718] |
| 2. Jingxia Du, Yibo Dong, Jingjing Song, Hanqi Shui, Chengyao Xiao, Yue Hu, Shiyao Zhou, Shanshan Wang. (2024) BMSC‑derived exosome‑mediated miR‑25‑3p delivery protects against myocardial ischemia/reperfusion injury by constraining M1‑like macrophage polarization. Molecular Medicine Reports, 30 (2): (1-15). [PMID:38904206] [10.3892/mmr.2024.13266] |
| 3. Sitong Ma, Jingbo Liu, Yajuan Li, Yingying Liu, Shanglin Li, Yang Liu, Ting Zhang, Meng Yang, Chunmei Liu, Zhiyang Du. (2025) Egg white-derived peptides co-assembly-reinforced zein/chondroitin sulfate nanoparticles for orally colon-targeted co-delivery of quercetin in colitis mitigation. Food Bioscience, [PMID:] [10.1016/j.fbio.2025.106161] |
| 4. Jingbo Liu, Yang Liu, Shanglin Li, LongJiang Tian, Yajuan Li, Chunmei Liu, Sitong Ma, Ting Zhang, Meng Yang, Zhiyang Du. (2025) Fructose-modified chitosan-based coassemblies reinforced oral bioavailability of egg white oligopeptides and curcumin via glucose transporter 2-oriented transcytosis and preferable mucus permeation. FOOD RESEARCH INTERNATIONAL, [PMID:40058919] [10.1016/j.foodres.2025.116065] |
| 5. Ye Zhou, Simeng Wang, Jiahua Guo, Chenghao Li, Mengjun Sui, Zekun Zeng, Hui Dang, Qingqing Gu, Jian Zhu, Yangyang Cheng, Peng Hou. (2024) Harnessing transcription factor-driven ROS for synergistic multimodal lung cancer treatment. JOURNAL OF CONTROLLED RELEASE, [PMID:39182692] [10.1016/j.jconrel.2024.08.035] |
| 6. Xi Tan, Jing Zhang, Yongyuan Heng, Lin Chen, Yi Wang, Shaojun Wu, Xiaoli Liu, Biao Xu, Ziyi Yu, Rong Gu. (2024) Locally delivered hydrogels with controlled release of nanoscale exosomes promote cardiac repair after myocardial infarction. JOURNAL OF CONTROLLED RELEASE, [PMID:38417558] [10.1016/j.jconrel.2024.02.035] |
| 7. Meng Yang, Jingbo Liu, Chunmei Liu, Hui Zhang, Shanglin Li, Ting Zhang, Zhipeng Yu, Xiwen Chi, Zhihui Zhang, Zhiyang Du. (2025) Programmable Food-Derived Peptide Coassembly Strategies for Boosting Targeted Colitis Therapy by Enhancing Oral Bioavailability and Restoring Gut Microenvironment Homeostasis. ACS Nano, [PMID:39745599] [10.1021/acsnano.4c11108] |
| 8. Qin Qian, Shan Zhiyan, Xing Lei, Jiang Yutong, Li Mengyue, Fan Linlin, Zeng Xin, Ma Xinrui, Zheng Danyang, Wang Han, Wang Hui, Liu Hao, Liang Shengjun, Wu Lijie, Liang Shuang. (2024) Synergistic effect of mesenchymal stem cell-derived extracellular vesicle and miR-137 alleviates autism-like behaviors by modulating the NF-κB pathway. Journal of Translational Medicine, 22 (1): (1-19). [PMID:38741170] [10.1186/s12967-024-05257-w] |
| 9. Na Yu, Wenbao Zuo, Linyu Ma, Jianhong Yang, Haliza Katas. (2024) Tailoring oleogel-in-hydrogel pickering emulsion fluid gels as an oral delivery system for different levels of dysphagia: From microstructure to rheological properties. FOOD HYDROCOLLOIDS, [PMID:] [10.1016/j.foodhyd.2024.110265] |
| 10. Haihua Zhou, Hongyan Pan, Faisal Raza, Hajra Zafar, Yu Ge, Nan Wang, Ronglei Zheng, Degeng Zhang, Yanmin Yang. (2024) Thermosensitive drug-loaded liposomes for photothermal and chemotherapeutic treatment of colon cancer. Materials Advances, 5 (6): (2456-2469). [PMID:] [10.1039/D3MA01060K] |
| 11. Jiawen Niu, Fawang Zhang, Chenlu Liu, Kunrong Xie, Yuanxiang Zhang, Jie Zhang, Xijun Wang, Chengchao Song, Boyuan Li, Yuhang Jiang, Tianlong Li, Yufu Wang. (2025) Magnetically Driven Biomimetic Microrobot Loaded with Eleutheroside B for Targeted Delivery and Neural Repair in Spinal Cord Injury. ACS Applied Materials & Interfaces, [PMID:40689443] [10.1021/acsami.5c07658] |
| 12. Yu-Zhang Wang, Wei-Hai Chen, Zi-Yi Han, Shi-Man Zhang, Ping Ji, Cheng Zhang, Jun-Long Liang, Xian-Zheng Zhang. (2025) Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids. Cell Metabolism, [PMID:40215982] [10.1016/j.cmet.2025.03.012] |
| 13. Yuchen Zhang, Shuang Feng, Jie Luo, Kaige Xu, Junfeng Guo, Xingyue Zhang, Mengxue Yuan, Qiang Luo, Yu Huang, Chaoqiang Fan, Kibret Mequanint, Donghui Zhu, Malcolm Xing, Shiming Yang. (2025) A Single-Metal-Doped Nanoplatform for Ferroptosis-Driven cGAS-STING Pathway Activation in Hepatocellular Carcinoma Immunotherapy. ADVANCED FUNCTIONAL MATERIALS, [PMID:] [10.1002/adfm.202520463] |
| 14. Qinglian Hu, Xiaoyu Huang, Tong Wang, Zhuoting Lu, Dongchang Sun, Yuanxiang Jin. (2025) Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy. ACS Applied Materials & Interfaces, [PMID:40375149] [10.1021/acsami.5c02850] |
| 15. Zishan Zeng, Jingwen Jiang, Yue Sun, Wanzhen Li, Dong Zheng, Huanxin Lin, Chunshun Zhao. (2025) Infected microenvironment responsive nanoprodrug for the specific therapeutics of Helicobacter pylori clearance. BIOMATERIALS, [PMID:40411983] [10.1016/j.biomaterials.2025.123415] |
| 16. Meng Zhuo-Nan, Chen Jian-Yuan, Yu Chong, Zheng Ai-hong, Reddy O. Sreekanth, Liu Kai-Yan, Su Yong-Rui, Zhang Shi-Tai, Wang Yin-Shuang, Gu Hang-Yu, Wang Fu-Wei, Xu Song-Cheng, Sun Li-Tao, Chen Bing-Chen, Lai Wing-Fu, Wu Guo-Qing, Zhang Da-Hong. (2025) A gelable polymer loaded with curcumin and apatinib absorbed in gelatin sponge delays postoperative residual tumor growth. Scientific Reports, 15 (1): (1-13). [PMID:40350449] [10.1038/s41598-025-97732-7] |
| 17. Xue Meng, Jianwen Song, Zekun Du, Yongyou Tao, Ji Qi. (2025) Microenvironment-Activatable Long-Wavelength NIR-II Visualization and Synergistic Treatment of Pulmonary Embolism. ACS Nano, [PMID:40499046] [10.1021/acsnano.5c07280] |
| 18. Chengjunyu Zhang, Sen Liu, Jianhui Zhang, Junlin Lu, Zehua Chen, Bolin Pan, Chu Liu, Ming Huang, Hengji Zhan, Hongjin Wang, Siting Chen, Kaiwen Jie, Baoqing He, Jingdie Wu, Ye Li, Haifeng Wang, Jing Zhao, Qiang Zhang, Xu Chen. (2025) A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy. Research, [PMID:40530387] [10.34133/research.0735] |
| 19. Chenxuan Shu, Yu Luo, Ye Liu, Junnan Wang, Qiang Qin, Ziwei Li, Jieying Situ, Xiaojing Liu, Xiangying Wang, Yan He, Qingsong Ye. (2025) Dental Pulp Stem Cell-Derived Intracellular Vesicles Promote Cartilage Regeneration and Alleviate Pain in Temporomandibular Joint Osteoarthritis. INTERNATIONAL DENTAL JOURNAL, [PMID:41192306] [10.1016/j.identj.2025.103974] |
| 20. Shijin Xu, Naidi Yang, Fangning Du, Ziying Zhang, Yin Zhang, Yixuan Zhang, Jiawei Liang, Yihan Zhao, Jiajun Zhang, Ziwei Zhang, Xiaoxuan Han, Zena Chen, Zhiqiang Zhou, Shu Zhang, Lin Li, Ying Lv. (2025) Mitochondrial-targeted photodynamic therapy combined with TGF-β inhibition potentiates anti-PD-1 therapy in pancreatic ductal adenocarcinoma. JOURNAL OF NANOBIOTECHNOLOGY, [PMID:41310702] [10.1186/s12951-025-03795-z] |
| 21. Lin Li, Tiantian Lei, Kejing Wang, Yong Liu, Bingjun Sun, Lin Chen. (2025) GPX4 Inhibitor-Driven Doxorubicin Homodimeric Prodrug Nanoassemblies with Synergistic Chemotherapy-Ferroptosis for Triple-Negative Breast Cancer Therapy. ACS Applied Nano Materials, [PMID:] [10.1021/acsanm.5c03980] |
| 22. Cai Cheng, Yan Lin, Xin Chen, Yang Xie, Xing Jiang, Jinting Chen, Yanling Wu, Zaiyi Luo, Jiayi Xu, Zhirong Zhang, Changguang Wang, Pei Jing, Zhongbing Liu, Xingjie Du, Jun Jiang, Xiaoduan Sun, Xiangyu Zhou, Zhirong Zhong. (2025) Nanoformulated resveratrol enhanced the treatment of atherosclerosis. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2025.172076] |
| 23. Qian-ni Wu, Zi-ren Feng, Qin Tang, Jiu-ping Jin, Xue-hui Liu, Zhi-bin Mai, Sheng-nan Zhao, Yong-qi Lan, Kai-xin Chen, Jin-duan Lin, Peng-cheng Xu, Ji-jun Fu. (2025) Redox-Active Cerium Oxide Nanoparticles Protect Against Acetaminophen-Induced Acute Liver Injury by Modulating Oxidative Stress and Inflammatory Pathways. MOLECULAR PHARMACEUTICS, [PMID:41472557] [10.1021/acs.molpharmaceut.5c01647] |
| 24. Lei Chen, Jianwen Song, Zhenya Shen, Ji Qi. (2026) NIR-II Light-Activated Nanoplatform for Synergistic Photothermal and H2S-Mediated Thrombolysis. Advanced Healthcare Materials, [PMID:41709443] [10.1002/adhm.202505802] |
| 25. Xi Tan, Simin Lu, Wangbei Qin, Xiaoqin Zhu, Xinlu Wang, Kaiwei Ren, Biwei Cheng, Jiahui Li, Dongze He, Ziran Hu, Yuhua Lei, Lixing Wu, Jing Zhang, Jiaxin Hu. (2026) From targeted delivery to inflammation suppression: engineering plant exosomes for heart failure therapy post-infarction. Materials Today Bio, [PMID:] [10.1016/j.mtbio.2026.103034] |
| 26. Weilin Wang, Xin Cui, Hengfa Wei, Jingjing Wang, Yesbolat Ahehati, Cuiping Jiang, Fei Li, Shasha Li. (2026) Sodium Alendronate-Modified PLGA-mPEG Nanomicelles Loaded with Rifapentine for Targeted Delivery to Bone Tissue. Pharmaceutics, 18 (3): [PMID:] [10.3390/pharmaceutics18030352] |
| 27. Zhang Rui Xue, Lu Weijia, Yan Xu, Deng Xudong, Wan Runrun, Song Zhejun, Liang Jiayan, Wang Xue-Ting, Cao Tingting, Chen Yan, Tam Paul K. H.. (2026) Rectal nanoparticulate-hydrogel delivering budesonide to reduce enterohepatic drug metabolism and clearance. Drug Delivery and Translational Research, [PMID:] [10.1007/s13346-026-02095-9] |